By Business/Source
Currency:USD
2026/Q3
Stock NameRevenueRatio
Single segment303K100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States486K100.00%
US Stock MarketDetailed Quotes
VistaGen Therapeutics (VTGN)
- 0.6258
- +0.0124+2.02%
Close May 1 16:00 ET
- 0.6300
- +0.0042+0.67%
Post 19:31 ET
24.79MMarket Cap-0.33P/E (TTM)
0.6355High0.6009Low427.44KVolume0.6141Open0.6134Prev Close267.52KTurnover1.27%Turnover RatioLossP/E (Static)39.62MShares5.140052wk High0.49P/B21.14MFloat Cap0.430052wk Low--Dividend TTM33.78MShs Float1889.9991Historical High--Div Yield TTM5.64%Range %0.4300Historical Low0.6259Avg Price1Lot Size
VistaGen Therapeutics (VTGN) Revenue Breakdown Overview
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm